Skip to content
OpenCapital
Get started

Boston Scientific BSX Cardiovascular — Goodwill acquired

Other segment segments

MedSurg
$274M—

Similar metrics at other companies

ResMed logo
RMDGoodwill on acquisition
$18.94M—
McKesson logo
MCKMedical-Surgical Solutions — Goodwill acquired
$0—
LivaNova logo
LIVNCardiopulmonary — Goodwill
$386.84M+6.5%
Capital One Financial logo
COFCredit Card — Goodwill
$14.56B+124%
Axon Enterprise, Inc. logo
AXONConnected Devices — Goodwill acquired
$0-100%
Rithm Capital logo
RITMResidential Transitional Lending — Goodwill acquired
$0—

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total debt$659.0M-94.1%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$65.77B-58.0%
P/E18.5×-44.2×
P/S3.2×-5.3×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity0×-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's cardiovascular — goodwill acquired.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's cardiovascular — goodwill acquired?
Boston Scientific (BSX) reported cardiovascular — goodwill acquired of $0 in Q1 2026.
How has Boston Scientific's cardiovascular — goodwill acquired changed year-over-year?
Boston Scientific's cardiovascular — goodwill acquired decreased by 100.0% year-over-year, from $205M to $0.
What is the long-term trend for Boston Scientific's cardiovascular — goodwill acquired?
Over 3 years (2021 to 2025), Boston Scientific's cardiovascular — goodwill acquired has grown at a -16.3% compound annual growth rate (CAGR), from $1.52B to $890M.
What does cardiovascular — goodwill acquired mean?
Reflects the value of goodwill added to the Cardiovascular segment balance sheet during the current reporting period due to new acquisitions. It highlights the company's inorganic growth strategy within the cardiovascular medical device market.